COLONSENTRY Canadian Trademark Information

On Thursday, August 14, 2008, a canadian trademark registration was filed for COLONSENTRY by StageZero Life Sciences Ltd. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1407257. The current status of this trademark filing is Registration published. The COLONSENTRY trademark is filed in the description of Diagnostic services, namely diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, and identifying physiological characteristics; medical and diagnostic services, namely diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, and monitoring of patient health progression; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating treatment progression, and prognosing disease or disease progression; and computer services, namely providing a website for patients and medical professionals featuring educational information about personalized health management, disease, and disease risk assessment services and screening products. , Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; diagnostic services, namely evaluating efficacy of treatment; medical and diagnostic services, namely evaluating clinical trial progress, and drug monitoring; providing genomic, proteomic and gene expression profiles useful in evaluating the efficacy and toxicity of treatments, and identifying disease heredity risk factors; and computer services, namely: computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics; and maintaining and providing access to a patient registry containing personalized health management information accessible via global, national and local computer networks. , Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; diagnostic services, namely evaluating efficacy of treatment; medical and diagnostic services, namely evaluating clinical trial progress, and drug monitoring; providing genomic, proteomic and gene expression profiles useful in evaluating the efficacy and toxicity of treatments, and identifying disease heredity risk factors; and computer services, namely: computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics; and maintaining and providing access to a patient registry containing personalized health management information accessible via global, national and local computer networks. , Diagnostic services, namely diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, and identifying physiological characteristics; medical and diagnostic services, namely diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, and monitoring of patient health progression; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating treatment progression, and prognosing disease or disease progression; and computer services, namely providing a website for patients and medical professionals featuring educational information about personalized health management, disease, and disease risk assessment services and screening products. .